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Abstract
MicroRNAs are key modulators at molecular level in different biological processes, including determination of cell fate and
differentiation. Herein, microRNA expression profiling experiments were performed on syngeneic cardiac (CStC) and bone
marrow (BMStC) mesenchymal stromal cells cultured in standard growth medium and then in vitro exposed to adipogenic,
osteogenic, cardiomyogenic and endothelial differentiation media. Analysis identified a tissue-specific microRNA signature
composed of 16 microRNAs that univocally discriminated cell type of origin and that were completely unaffected by in vitro
differentiation media: 4 microRNAs were over-expressed in cardiac stromal cells, and 12 were overexpressed or present only
in bone marrow stromal cells. Further, results revealed microRNA subsets specifically modulated by each differentiation
medium, irrespective of the cell type of origin, and a subset of 7 microRNAs that were down-regulated by all media with
respect to growth medium. Finally, we identified 16 microRNAs that were differentially modulated by the media when
comparing the two tissues of origin. The existence of a tissue-specific microRNA signature surviving to any differentiation
stimuli, strongly support the role if microRNAs determining cell identity related to tissue origin. Moreover, we identified
microRNA subsets modulated by different culture conditions in a tissue-specific manner, pointing out their importance
during differentiation processes.
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Introduction
microRNAs (miRs) are 21–23 nucleotide non-coding RNA
molecules, which modulate the stability and/or the translational
efficiency of messenger RNAs (mRNA). Since miRs may target
multiple transcripts and individual transcripts may be subject to
multiple miR regulation, it is easy to appreciate that most
biological processes are, at least in part, under the influence of
miRs [1]. Interestingly, evidences have been provided that miRs
can have binding motifs also located in the promoter regions [2] or
into the sequence of long non-coding RNA [3], thus enormously
extending their possible functions. Importantly, miR have been
involved in pluripotency maintenance [4], cell proliferation and
differentiation [5], epithelial to mesenchymal transition [6],
senescence [7], and apoptosis [8].
Due to their wide role in cell process regulation, miR have
gained popularity also as tools that are able to promote direct cell
to cell phenotypic conversion as well as adult cell reprogramming
into pluripotent stem cells. In fact, it has been recently
demonstrated that miRs have the possibility to induce fibroblast
differentiation into cardiomyocyte-like cells [9] and to facilitate, in
concert with specific transcription factors, the conversion of adult
human fibroblasts into neurons [10] or cardiomyocyte-like cells
[11]. In addition, miRs might promote adult cell reprogramming
into pluripotent cells [12,13], although further work has to be done
to understand whether miRs alone are sufficient to reprogram
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somatic cells into stem cells or other type of specialized cells.
Nevertheless, being able to regulate and, possibly, to fine tune cell
fate, miRs appear as a new frontier for application in regenerative
medicine.
We recently characterized a population of cardiac mesenchymal
stromal cells (CStC) from adult human atrial appendages [14].
This fibroblast-like, plastic-adherent cell population shared the
expression of mesenchymal-associated antigens (i.e. CD105,
CD73, CD29, and CD44) with stromal cells from other tissues.
Nevertheless, it also exhibited specific properties, like a more
pronounced ability than stromal cells of bone marrow origin
(BMStC) of differentiating towards cardiomyocyte and endothelial
phenotypes both in in vitro and in vivo settings. Being easily
obtainable from small biopsy specimens and amplifiable in vitro
up to therapeutically suitable numbers, CStC appear as a cell
population useful for regenerative medicine applications.
In order to contribute in clarifying miR role in the definition of
stromal cell identity and fate we: (1) isolated CStC and BMStC
from syngeneic donors and cultured them in standard growth
conditions (2) exposed them to four media previously used in
literature to promote their differentiation into adipocyte, osteo-
cyte-, endothelial-, cardiomyocyte-like cells and (3) analyzed their
miR profile before and after differentiation treatments.
Specific aims of the present work were to: (1) identify a tissue-
specific miR expression signature which was not influenced
in vitro by differentiation media; (2) identify miR subsets
specifically modulated by each differentiation medium, indepen-
dently from the cell type of origin; and (3) identify those miRs that
are differently modulated by the media between the two cell types.
To do so, we used a two-factor experimental approach that
allowed us to ascertain miRs that unequivocally discriminated the
cell type of origin, miRs that are similarly modulated by
differentiation media in both cell types, and miRs that are
differentially modulated by the media in the cell types. In addition,
bioinformatics tools were used to relate miR expression to their
predicted and/or validated mRNA targets in order to propose an
interpretation of the results in terms of functional consequences on
cell function, stemness and regenerative potential.
Materials and Methods
Ethics Statement
CStC and BMStC were obtained respectively from right auricle
and sternal marrow samples of the same donor patients (n=4)
undergoing cardiac surgery, after approval by the Centro
Cardiologico Monzino (Milano, Italy) Local Ethics Committee
and signed informed consent. Experiments were conducted in
accordance to the principles expressed in the Declaration of
Helsinki. All data were analyzed anonymously.
CStC and BMStC isolation and culture
CStC and BMStC were isolated as described in [14]. Briefly,
CStC were enzymatically isolated from small auricle fragments
using 3 mg/ml collagenase (Serva) and cultured in standard
growth medium (GM), composed of Iscove’s Modified Dulbecco’s
Medium (IMDM, Lonza) supplemented with 20% fetal bovine
serum (FBS, Hyclone), 10 ng/ml basic Fibroblasts Growth Factor
(bFGF, R&D), 10.000 U/ml Penicillin/Streptomycin (Invitrogen),
20 mM L-Glutamine (Sigma-Aldrich). BMStC obtained from
5 ml of heparinized bone marrow were separated by stratification
on Ficoll gradient and cultured in the same GM.
In vitro cell differentiation
CStC and BMStC were plated at a density of 5000 cells/cm2
and exposed to standardize differentiation-inducing media for 21
days. Media were changed twice a week. Adipogenic and
osteogenic differentiation were achieved following standard
in vitro protocols [15]. Endothelial differentiation was stimulated
by culturing the cells in Endothelial Growing Medium 2 (EGM-2,
Lonza), while differentiation towards the cardiomyogenic lineage
was stimulated by culturing the cells in a medium composed by
IMDM with 5% FBS (EuroClone), 5 mM All-Trans Retinoic Acid
(ATRA) and 5 mM phenylbutyrate (PB, Sigma-Aldrich), as
previously described [14]. After exposure to adipogenic, osteo-
genic and cardiomyogenic media, cells stopped proliferating, so
they were not passaged anymore and the media were changed
twice a week. On the contrary, cells exposed to endothelial and
growth medium kept on proliferating and were consequently
trypsinized and passaged when reaching 80–90% of confluence
(usually every two or three days).
Intracellular lipid staining by Oil-Red O
The accumulation of lipid droplets was evaluated by Oil-Red O
staining [16]. The quantification of Oil-Red O positive cells was
obtained by counting the number of positive cells vs. total number
of cells.
Von Kossa staining
The production of mineralized matrix was evaluated by von
Kossa staining as previously described [16].
Alkaline phosphatase assay
The presence of alkaline phosphatase was evaluated according
to manufacturer’s instructions (AnaSpec).
Ac-LDL-DiI uptake
Cells were incubated with 1,1-dioctadecyl-3,3,3,3-tetramethy-
lindocarbocyanine-labeled acetylated LDL (Ac-LDL-DiI, Biomed-
ical Technologies) as indicator of endothelial cells differentiation
[16,17]. After fixation with 4% PFA, cells were counterstained
with Hoechst 33258 nuclear and observed with a Zeiss microscope
equipped for epifluorescence.
Flow cytometry
Cells were detached using 0.02% EDTA solution (Sigma-
Aldrich) and stained with VEGFR2 PE-conjugated antibody
(R&D) for 10 min at room temperature in the dark. In a different
tube, cells were incubated with the correspondent IgG isotype,
conjugated with the same fluorochrome used for the primary
antibody. Cells were analyzed using a FACSCalibur (Becton–
Dickinson) equipped with Cell-Quest Software v2.4.
Immunofluorescence
a-sarcomeric actin expression was detected by incubation with
specific primary antibody (AbCam) and FITC-conjugated second-
ary antibody (Jackson Immunoresearch). Nuclei were counter-
stained with Hoechst 33258 (Sigma-Aldrich) [14].
microRNA profiling
Total RNA was extracted from cells using TRIzol reagent
(Invitrogen) in accordance to the manufacturer’s instruction. Total
RNA concentration and purity were evaluated by a NanoDrop
1000 spectrophotometer (Thermo Scientific), while RNA integrity
was assessed with an Experion electrophoresis system and RNA
High Sense Analysis Kit (Bio-Rad). Only high quality RNAs, with
MiR Signatures in Differentiating Stromal Cells
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Figure 1. Morphology and response to in vitro differentiation. (A) Cardiac (CStC) and Bone Marrow (BMStC) Stromal Cells cultured in standard
growth medium (GM). (B) CStC and BMStC exposed to adipogenic media (AM) show intracellular lipid accumulation as evidenced by Oil-red O
staining. (C) Von Kossa staining of CStC and BMStC after osteogenic treatment: mineralized matrix is visualized by black dots. (D) Immunostaining for
a-sarcomeric actin, a marker of cardiomyogenic differentiation. (E) Ac-LDL uptake assay: red in cytoplasm represents DiI-labeled acetylated LDL.
Original magnifications: 106for panels A, B, and C, and 406for panels D and E. (F) Percentage of CStC and BMStC positive to Oil-red O staining in GM
and after exposure to AM. (G) Accumulation of alkaline phosphatase was evaluated in CStC and BMStC cultured in GM and exposed for 21 days to
osteogenic medium (OM). (H) RT-qPCR analysis for a-sarcomeric actin expression in CStC and BMStC after 3 weeks culture in GM and cardiomyogenic
medium (CM). (I) Bar graph showing quantitative results for the Ac-LDL-DiI uptake in CStC and BMStC cultured in GM and exposed to endothelial
medium (EM). (L) Representative flow cytofluorograms and bar graph indicating the percentage of VEGFR2 positive cells evaluated by FACS
MiR Signatures in Differentiating Stromal Cells
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A260/A280 and A260/A230 ratios .1.8 and a RQI$9.5/10,
were used for subsequent investigations. Comparative miR
expression profiling was carried out using the TaqMan Low
Density Array Human MicroRNA Panel (Applied Biosystems),
according to the manufacturer’s instructions, using a 7900TH
Real Time PCR System (Applied Biosystems).
Prior to the analysis, probes were renamed and reannotated
according to miRBase Release 20 (http://www.mirbase.org) [18].
This allowed us identifying 360 target sequences unique to human
miRs, discarding probes for tRNA, snoRNA, and misannotated
sequences. Expression analysis and quality control of TaqMan
Arrays were performed using the ExpressionSuite Software v1.0.3
(Applied Biosystems). All Ct values reported as greater than 40 or
as not detected were changed to 40 and considered a negative call.
Raw expression intensities of target miRs were normalized for
differences in the amount of total RNA added to each reaction
using the mean expression value of all expressed miRs in a given
sample [19]. Relative quantitation of miR expression was
performed using the comparative Ct method (DDCt). MiRs were
deemed as non informative and filtered out when the percentile of
negative calls exceeded 6 (20% of the samples): thus, the number
of miRs considered for subsequent analysis was 306.
Reverse Transcription – Real-time Polymerase Chain
Reaction Analysis (RT-qPCR)
For gene expression analysis 1 mg of total RNA was reversely
transcribed using the Superscript III reverse transcriptase (Invitro-
gen). cDNA was amplified by SYBR-GREEN quantitative PCR
on an iQ5 Cycler (Bio-Rad). The following primers were used to
detect a-sarcomeric actin transcript expression: forward 59-
TGTCCTGAGACACTCTTC-39; reverse 59-TGATGC-
TATTGTAAGTTGTT-39. Samples were normalized to the Ct
value of GAPDH, chosen as internal control. Relative quantitation
was performed using the DDCt method. Fold changes in gene
expression were estimated as 2(2DDCt) [20].
To validate array-derived expression data, individual miR
expression was analyzed using specific single-assay primers and
target probes (Applied Biosystems) for miR-1, 126-5p, 133b, 135a-
5p, 142-5p, 146a-5p, 155-5p, 184, 204-5p, and 222-3p. Reverse-
transcription and real-time reactions were performed according to
the manufacturer’s instructions, using a 7900TH Real Time PCR
System (Applied Biosystems). Raw expression intensities of target
miRs were normalized using the mean expression value of RNU44
and U6 RNA in any given sample. Relative quantitation was
performed using the DDCt method.
Statistical analysis
The MeV v4.9.0 software [21] was used for the primary
statistical and for unsupervised hierarchical clustering analyses.
The GraphPad Prism v5.03 software was used for post-hoc
analyses. Array data were analyzed by 2-factor ANOVA,
calculating the P-values based on the F-distribution. In order to
control for the false discovery rate (FDR), a q-value was estimated
for each gene [22], both for the effects of the two factors and for
the interaction P-value, using the QVALUE v1.36.0 implemented
in Bioconductor v2.13 software package. The q-value was used as
a FDR-based measure of significance and the threshold a was set
to #0.01. Bonferroni post-hoc test was used to compare the effects
of each medium within cells (vs. GM) and between cells (CStC vs.
BMStC) and adjusted P-values ,0.05 were considered statistically
significant. Linear regression analysis and calculation of Pearson
correlation coefficients were performed to relate array to
singleplex qPCR expression data.
Bioinformatics analysis
Queries for miR target prediction with three different
algorithms (miRanda, PITA and TargetScan) was performed
using the web-based tool MAGIA [23], applying stringent score
filters (-12 for PITA, 500 for miRanda). Experimentally validated
microRNA-target interactions were retrieved from the miRTar-
Base repository Release 4.5 [24]. The gene lists generated by these
queries were exploited for gene-annotation (Gene Ontology, GO,
terms and KEGG pathways) enrichment analysis using the web-
based application DAVID 6.7 [25]: the EASE score (a conserva-
tive adjustment of the Fisher Exact P-value) threshold was set to
0.005 for GO terms and 0.05 for KEGG pathways. Redundant
GO terms were removed using the web-based tool REViGO [26],
with an allowed similarity threshold of 0.5. Irrelevant gene sets
were removed manually.
Functional analysis of validated target genes for those miRs
showing a statistically significant interaction between tissue and
medium was performed using the Cytoscape [27] plugin ClueGO
v2.1.2 [28], which allows analyzing and visualizing non-redundant
biological terms for large lists of genes in a functionally grouped
network. The network is created with kappa statistics, which
reflects the relationships between the terms based on the similarity
of their associated genes. ClueGO enrichment was calculated as a
two-sided (enrichment/depletion) test based on the hypergeo-
metric distribution, correcting for multiple testing by the
Benjamini-Hochberg method. Percentage for cluster specificity
was fixed to $55% and kappa score threshold for functional
grouping to $0.3. Terms with an adjusted P-value,0.001 were
selected for network visualization.
Results
Stromal cells obtained from different tissues show similar
morphology and immunophenotype but different plastic proper-
ties [29]. Consistently with our previous results [14], CStC
exhibited lower ability to gain both adipocyte and osteocyte
features, esteemed by Oil-red O, Von Kossa staining and alkaline
phosphatase measurements (Figure 1A, B, F, G). We also
confirmed that CStC [30] displayed greater propensity to
differentiate into cardiomyocyte-like and endothelial-like cells
when compared to BMStC [31]. This was demonstrated after 21
days of differentiating treatment by (i) a higher expression of a-
sarcomeric actin (evaluated by immunofluorescence and RT-
qPCR, Figure 1D, H), (ii) a more efficient accumulation of Ac-
LDL (Figure 1E, I), and (iii) a higher number of VEGFR2 positive
cells (Figure 1L). Of note, both CStC and BMStC in growth
medium (GM) exhibited negligible spontaneous differentiation.
This different behavior is likely due to distinct molecular networks
activated or repressed in the two cell populations despite their
phenotypical similarity. To prove this hypothesis, miR expression
profiles were evaluated by low-density microRNA TaqMan array
in both CStC and BMStC exposed for 21 days to standard culture
conditions (GM) or to four differentiation media, namely
Adipogenic (AM), Osteogenic (OM), Cardiomyogenic (CM), and
Endothelial (EM) Media. Differentially expressed genes were
expression in CStC and BMStC before and after 3 weeks of EM culture. All the bar graphs show the mean values of 3 independent experiments 6 SD
(unpaired Student t-test: *P,0.001 vs. corresponding GM, 1P,0.001 vs. BMStC).
doi:10.1371/journal.pone.0107269.g001
MiR Signatures in Differentiating Stromal Cells
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sought by performing a 2-way ANOVA, the two factors being the
tissue of origin and the medium to which cells were exposed.
Results obtained by this analysis led us to identify a grand-total of
115 significantly modulated miRs (after correction for multiple
comparisons with a FDR#0.01) either by the tissue of origin, or by
the differentiation media, or by the interaction between the two
factors (Table S1).
An unsupervised hierarchical clustering (Figure 2) revealed that
the expression profile of these 115 miRs was able to fully
discriminate medium-differentiated cells, i.e. cells of the same
origin cultured in the same conditions were grouped in distinct
nodes of the sample dendrogram. Interestingly, also CStC and
BMStC cultured in GM belonged to the same main cluster, but a
deeper insight revealed that only cells #1, 3, and 4 clustered
according to the tissue of origin: CStC and BMStC from patient
#2 grouped together in a distinct sub-cluster. This might be due to
specific characteristics or different genetic background of patient
#2, although the survey of his clinical records did not evidence
anything that could explain his different behavior.
Tissue-specific miR profiles
Among the 115 differentially modulated miRs, 41 miRs were
dependent on the tissue of origin. Accordingly, the unsupervised
hierarchical clustering showed that these 41 miRs were able to
divide CStC and BMStC into two different clusters independently
of the culture conditions (Table S1). We then used a Venn
diagram (Figure 3A) to visualize which miRs were exclusively
influenced by the tissue of origin, excluding those miRs that were
modulated also or solely by the culture medium and/or by the
interaction between the two factors. The remaining subset was
composed of 19 miRs that were independent from and unmodu-
lated by any differentiation stimuli. To further refine this tissue-
specific miR profile, we excluded 3 miRs that showed a mean fold
difference between CStC and BMStC#|62| (i.e. miR-214-3p,
324-3p, and 365a-3p). This allowed us to identify two tissue
specific miR signatures (Figure 3B), which included: 4 miRs that
were significantly overexpressed in CStC (miR-146a-5p, 211-5p,
532-5p, and 660-5p); 8 miRs overexpressed in BMStC (miR-10a-
5p, 199a-3p, 199a-5p, 224-5p, 299-5p, 376a-5p, 497-5p, and 618)
plus 4 BMStC-specific miRs that were virtually absent in CStC
(miR-10b-5p, 196a-5p, 196b-5p, and 615-3p).
Importantly, gene-annotation enrichment analysis, conducted
on both predicted and validated targets of the two miR signatures,
showed that several pathways and gene categories are targeted by
both CStC and BMStC specific miRs, e.g. calcium, insulin,
MAPK, ErbB, Jak-STAT, mTOR, and Wnt signaling pathways
(not shown). Conversely, this analysis (Figure 3C and D) revealed
a number of distinct unique GO biological processes (blue-colored
bars), molecular functions (green), and KEGG pathways (red),
which are potentially targeted by the signature miRs in either cell
populations.
Medium-specific miR profiles
Two-way ANOVA identified 95 miRs that were significantly
modulated by the differentiation media (Table S1). The Venn
diagram analysis (Figure 3A) showed that 13 miRs were influ-
enced by both the tissue of origin and the media (upper
intersection area), i.e. that they were differentially expressed
between BMStC and CStC and that one or more media
modulated their expression similarly in both cell types. In addition,
the Venn diagram revealed 67 miRs that were exclusively
influenced by differentiation media, independently from the tissue
of origin (i.e. no significant differential expression between the cell
types, but a significant modulation in the same direction and of a
Figure 2. Unsupervised hierarchical clustering of miRs influ-
enced by tissue of origin and/or differentiation media and/or
interaction. Two-way ANOVA identified 115 miRs significantly mod-
ulated (FDR#0.01). Samples and miRs were clustered using Pearson’s
correlation (centered) and average linkage method. Each combination
of cell type and differentiation medium was grouped in distinct clusters.
The relative expression level of each miR is represented with a blue,
black, and orange color scale, ranging from samples with 22 to +2
standard deviations from the mean (blue indicates below median; black,
equal to, and orange, above median). CStC, Cardiac and BMStC, Bone
Marrow Stromal Cells; GM, growth medium; AM, Adipogenic Medium;
OM, Osteogenic Medium; CM, Cardiomyogenic Medium; EM, Endothe-
lial Medium.
doi:10.1371/journal.pone.0107269.g002
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Figure 3. miR tissue signature and its potential functional implications. (A) A Venn diagram of the 115 significantly modulated miRs helps
indentifying those exclusively affected by the tissue of origin (upper left segment) or by one or more differentiation media (upper right), and those
influenced by both factors (upper mid intersection) or by the interaction between the two (lower intersection segments). (B) Unsupervised
hierarchical clustering defining the miR tissue signature composed by 16 miRs, distinctive of the tissue of origin and with at least a 2-fold difference.
Log2 transformed miR expression signals were centered by median values and samples and miRs were clustered using Pearson’s correlation
(centered) and average linkage method, with leaf order optimization. The dendrogram above shows that this signature is able to divide Cardiac
(CStC) and Bone Marrow (BMStC) Stromal Cells in two distinct clusters, irrespective of the culture media exposure. The relative expression level of
each miR is represented with a green, black, and red color scale (green indicates below, black equal to, and red above median). (C) Gene-annotation
enrichment analysis revealed GO biological processes (blue bars), molecular functions (green), and KEGG pathways (red) potentially and exclusively
targeted by CStC tissue-specific miRs. The x-axis represents the percentage of genes belonging to a given GO or KEGG term with respect to the total
predicted and validated targets. EASE score P-values are reported for every term. (D) Gene categories potentially targeted by BMStC tissue-specific
miRs, as revealed by gene-annotation enrichment analysis. GM, growth medium; AM, Adipogenic Medium; OM, Osteogenic Medium; CM,
Cardiomyogenic Medium; EM, Endothelial Medium.
doi:10.1371/journal.pone.0107269.g003
MiR Signatures in Differentiating Stromal Cells
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similar extent in both CStC and BMStC). Importantly, unsuper-
vised hierarchical clustering indicated that these 80 miRs were
able to fully discriminate cells exposed to the same medium,
independently from their tissue of origin (Figure 4A).
Post-hoc tests, conducted comparing each differentiation
medium with the GM, combining BMStC and CStC data,
allowed identifying smaller subsets of miRs specifically modulated
in each condition (Table 1). Among them, miR-7-5p, 15b-5p, 18a-
5p, 20a-5p, 31-5p, 155-5p, and 629-3p were significantly down-
regulated by all media in both cells, while other subsets were
specifically modulated by one or more differentiation conditions,
with a fold change (FC) $|62| in most cases (Table 1).
Figure 4. miRs specifically influenced by differentiation media. (A) Heatmap representing the expression of 80 miRs significantly modulated
by differentiation stimuli (FDR#0.01) independently from the tissue of origin. Unsupervised hierarchical analysis groups in five distinct clusters both
Cardiac (CStC) and Bone Marrow (BMStC) Stromal Cells exposed to the same medium, as highlighted by translucent purple wedges drawn from the
five main nodes. Clustering was done using Pearson’s correlation (centered) and average linkage method. The relative expression level of each miR is
represented with a green, black, and red color scale (as in Figure 3). Gene-annotation enrichment analysis showed relevant GO biological processes
and KEGG pathways potentially targeted by miRs modulated by (B) Adipogenic Medium (AM), (C) Osteogenic Medium (OM), (D) Cardiomyogenic
Medium (CM), and (E) Endothelial Medium (EM). EASE score P-values are reported for every term.
doi:10.1371/journal.pone.0107269.g004
MiR Signatures in Differentiating Stromal Cells
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In agreement with the expected effect on cell phenotype, a look-
up of gene-annotation enrichment analysis revealed that miRs
exclusively modulated (i) by AM may target pathways related to
the lipid metabolism, (ii) by CM processes linked to cytoskeleton
organization and calcium handling, (iii) by OM phosphate
homeostasis and mineralization, and (iv) by EM vessel and
endothelial cell proliferation (Figure 4B).
Interaction effects
Two-way ANOVA identified a group of 16 miRs, which
showed a statistically significant interaction effect of the media
on the cell type (Figure 5), i.e. miRs that were differentially
modulated by one or more media in CStC vs. BMStC. In detail,
the Venn diagram (Figure 3A) shows that the expression of one
miR (362-5p) is influenced by both cell type and interaction, 7 by
media and interaction (130a-3p, 135a-5p, 142-5p, 24-1-5p, 27b-
3p, 30d-5p, 511-5p), and 8 by both factors (tissue and medium)
and interaction (1, 133b, 184, 204-5p, 216a-5p, 222-3p, 29a-3p,
503-5p). Post-hoc analysis comparing CStC and BMStC allowed
identifying subsets of miRs affecting differentiation in a cell-
specific manner (Figure 5). Four subsets were distinctively
modulated in CStC. The first subset comprises 5 miRs (142-5p,
216a-5p, 27b-3p, 30d-5p, and 511-5p) that were all up-regulated
by AM in CStC to a significantly higher level than in BMStC
(mean fold difference of 15.2, 17.5, 3.5, 2.3, and 3.1, respectively).
A second subset consists of 7 miRs (1, 133b, 184, 204-5p, 24-1-5p,
362-5p, and 503-5p) up-regulated by OM in CStC and
significantly higher than in BMStC (fold difference of 4.5, 42.4,
71.8, 432.7, 3.4, 6.3, and 6.6, respectively). The third subset
includes 3 miRs (1, 135a-5p, and 27b-3p) up-regulated by CM in
CStC to a significantly higher extent than in BMStC (fold
difference of 5.0, 60.0, and 1.7, respectively). Finally, miR-204-5p
was up-regulated in CStC also by EM, with a significant fold
difference of 22.3 compared to in BMStC. Conversely, two miRs
(130a-3p and 511-5p) were up-regulated by OM and CM,
respectively, in BMStC but not in CStC (with significant fold
differences of 2.9 and 5.7). In addition, miR-222-3p was down-
regulated by all differentiation media but EM in both cell types,
showing a significant higher expression in BMStC vs. CStC
cultured in GM (3.2), AM (3.4), and EM (1.7); miR-29a-3p was
Figure 5. miRs for which the effect of the media differed between CStC and BMStC. Mean expression levels 6 SEM are plotted for 16 miRs
showing a significant interaction effect between tissue origin and media, at 2-way ANOVA, for both Cardiac (CStC) and Bone Marrow (BMStC) Stromal
Cells (open circle and filled squares, respectively). Post-hoc comparison between CStC and BMStC indentified miRs differentially modulated by
differentiation media. *P,0.05, **P,0.01, ***P,0.001. GM, growth medium; AM, Adipogenic Medium; OM, Osteogenic Medium; CM, Cardiomyogenic
Medium; EM, Endothelial Medium.
doi:10.1371/journal.pone.0107269.g005
MiR Signatures in Differentiating Stromal Cells
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e107269
down-regulated by OM in CStC (-4.3), and was significantly
higher in BMStC than CStC cultured in OM (8.0) and EM (1.7).
Experimentally validated targets of the four CStC-related miR
subsets were analyzed for gene set enrichment and compared to
construct a functionally grouped GO and KEGG pathway
annotation network, which visualizes the differences of the four
gene clusters (Figure 6). This analysis uncovered, besides func-
tional terms not specific to any differentiation media, GO/KEGG
gene sets explicitly targeted in CStC by miR subsets modulated by
CM (cardiac muscle differentiation, response to cyclic compound
second messenger system, MAPK signaling cascade), OM (fatty
acid transport, cell cycle and apoptosis, cell adhesion), and AM
(negative regulation of TOR signaling). No EM-specific gene set
was evident. Table 2 summarizes the results of gene set
enrichment analysis of the validated targets of the other miRs:
miR-204-5p, consistently with its up-regulation by EM and OM in
CStC, has an impact both on vasculature and skeletal system
development. Target genes of miR-130a-3p are involved in the
BMP and TGF-b signaling pathways and the regulation of
osteoblast differentiation; those of mir-222-3p in cell cycle,
response to stress and cytoskeleton organization; and those of
miR-29a-3p in regulation of cell adhesion and regulation of
ossification.
Figure 6. Differentiation cluster network based on functionally enriched GO terms and KEGG pathways. Functional differences of the
over-represented GO Biological Processes (BP) and KEGG pathways for the adipogenic, osteogenic, and cardiomyogenic differentiation stimuli in CStC
are shown. GO BP and pathway terms are represented as nodes and functional groups are linked to their biological function. Node labels show the
most significant or relevant group gene set. Node size represents the term enrichment significance. Node color represents specific cluster
membership, i.e. adipogenic (blue), osteogenic (green) or cardiomyogenic (red) differentiation clusters; grey nodes represent unspecific cluster
related terms. Node color gradient (from lighter to darker) refers to the proportion of genes (ascending) of a specific differentiation cluster.
doi:10.1371/journal.pone.0107269.g006
MiR Signatures in Differentiating Stromal Cells
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e107269
Table 2. Gene set enrichment analysis of 4 miRs differentially modulated by differentiation media in CStC vs. BMStC.
Term ID Description N* %{ P-value`
miR-204-5p
GO:0001944 vasculature development 9 12.5 3.18E-05
GO:0051173 positive regulation of nitrogen compound metabolic process 13 18.1 6.61E-05
GO:0006357 regulation of transcription from RNA polymerase II promoter 13 18.1 2.08E-04
GO:0009611 response to wounding 11 15.3 2.60E-04
GO:0010558 negative regulation of macromolecule biosynthetic process 11 15.3 3.34E-04
GO:0001501 skeletal system development 8 11.1 9.82E-04
GO:0016044 membrane organization 8 11.1 2.71E-03
GO:0014070 response to organic cyclic substance 5 6.9 3.02E-03
GO:0018107 peptidyl-threonine phosphorylation 3 4.2 3.51E-03
GO:0048870 cell motility 7 9.7 4.07E-03
GO:0042127 regulation of cell proliferation 11 15.3 5.00E-03
hsa04210 Apoptosis 5 6.9 3.10E-03
hsa04621 NOD-like receptor signaling pathway 4 5.6 9.26E-03
hsa04060 Cytokine-cytokine receptor interaction 7 9.7 9.33E-03
hsa04520 Adherens junction 4 5.6 1.67E-02
miR-130a-3p
GO:0007389 pattern specification process 8 32.0 2.02E-07
GO:0010604 positive regulation of macromolecule metabolic process 11 44.0 5.30E-07
GO:0045941 positive regulation of transcription 8 32.0 2.89E-05
GO:0030509 BMP signaling pathway 4 16.0 5.43E-05
GO:0042127 regulation of cell proliferation 8 32.0 2.37E-04
GO:0019220 regulation of phosphate metabolic process 6 24.0 1.14E-03
GO:0042592 homeostatic process 7 28.0 1.28E-03
GO:0045667 regulation of osteoblast differentiation 3 12.0 2.39E-03
GO:0006897 endocytosis 4 16.0 5.91E-03
hsa04350 TGF-beta signaling pathway 4 16.0 9.52E-04
hsa04144 Endocytosis 4 16.0 8.05E-03
hsa04060 Cytokine-cytokine receptor interaction 4 16.0 2.10E-02
miR-222-3p
GO:0007049 cell cycle 30 10.9 7.41E-05
GO:0046907 intracellular transport 26 9.5 1.82E-04
GO:0006461 protein complex assembly 22 8.0 1.85E-04
GO:0010608 posttranscriptional regulation of gene expression 13 4.7 3.09E-04
GO:0010605 negative regulation of macromolecule metabolic process 26 9.5 9.34E-04
GO:0006396 RNA processing 21 7.7 1.32E-03
GO:0007017 microtubule-based process 13 4.7 1.53E-03
GO:0007010 cytoskeleton organization 18 6.6 1.54E-03
GO:0051173 positive regulation of nitrogen compound metabolic process 23 8.4 1.86E-03
GO:0006261 DNA-dependent DNA replication 6 2.2 3.23E-03
GO:0006357 regulation of transcription from RNA polymerase II promoter 24 8.8 3.80E-03
GO:0042493 response to drug 11 4.0 4.42E-03
GO:0033554 cellular response to stress 20 7.3 4.47E-03
hsa03030 DNA replication 5 1.8 4.42E-03
hsa04530 Tight junction 7 2.6 4.02E-02
miR-29a-3p
GO:0001952 regulation of cell-matrix adhesion 4 5.7 2.25E-04
GO:0001775 cell activation 8 11.4 2.65E-04
GO:0051130 positive regulation of cellular component organization 6 8.6 1.22E-03
GO:0010035 response to inorganic substance 6 8.6 2.11E-03
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Singleplex RT-qPCR validation
Single RT-qPCR experiments were performed for 10 miRs to
validate data derived from the arrays (Figure 7). To cover all
possible combinations, we chose one miR from the tissue signature
(miR-146a-5p), one modulated by all media but not differentially
expressed between the cell types (155-5p), seven with a significant
interaction q-value and influenced by both tissue and medium (1,
133b, 135a-5p, 142-5p, 184, 204-5p, and 222-3p), and one miR
that was not significantly different between cell types and among
differentiation media (126-5p). Results fully confirmed the array
data, as the Pearson coefficient was $0.70 and P-values,0.001
for every correlation analysis.
Discussion
MicroRNAs have been suggested to be part of the molecular
network responsible for cell identity regulation [14,32]. In the
present work, we verify that stromal cells obtained from different
tissues retain unaltered the expression of miR subsets even after
differentiation [14] and highlight significant influences of diverse
differentiation strategies on miR expression profiles. Most
interestingly, our results pointed out an interaction between
culture media and tissue of origin in determining miR expression
of a given cell type and affecting differentiation in a cell-specific
manner.
MiRs included in the tissue signature remained unmodified
after in vitro standard differentiation treatments. This observation
has important consequences, confirming that miR-regulated
pathways are involved in cell identity and fate determination.
Among the 16 miRs constituting the BMStC specific signature,
miRs-10a, 10b, 196a, 196b, 199a and 615 have a role in
controlling cell cycle, proliferation and development [33,34]. Of
note, miR-146a, is highly expressed in proliferating cardiovascular
precursors [35], consistently with its higher expression in CStC
compared to BMStC. Importantly, GO analysis revealed that miR
specifically overexpressed in BMStC might target processes
involved in phosphorous metabolism, which is in line with the
increased osteogenic ability of BMStC compared to CStC. On the
other hand, miR specifically up-regulated in CStC can actually
target transmembrane ion movement and toll-like receptor
signaling pathways. These findings are in agreement with the
ability of CStC to acquire some excitable cell properties [30] and
to respond to HMGB-1 stimulation [36], respectively.
MiRs modulated only by differentiation stimuli independently
from tissue origin were expressed at similar levels in CStC and
BMStC cultured in GM and significantly modulated at a
comparable extent and direction in the two cell populations after
differentiation treatment. Within this group, a smaller subset of
7 miRs was significantly down-regulated by all the differentiating
conditions. The down-modulation of miR-155, 20a-5p, and 18a-
5p is consistent with the reduced proliferation ability observed
during differentiation processes, in agreement with their involve-
ment in cell proliferation and apoptosis suppression [37,38].
Further, suppression of miR-7-5p and miR-31-5p is related to
differentiation processes, such as osteogenesis [39], myogenic
differentiation [40], and vascular development [41]. Other miRs
appeared to be regulated mainly by one differentiation stimulus.
Members of the let-7 family, together with miR-23a and 23b, were
significantly up-regulated after cardiomyogenic treatment, in
agreement with their reported role in cardiac differentiation [42]
and cardiovascular processes [43]. Similarly, miR-320, 193 and
125a, which were significantly up-regulated after osteogenic
treatment, have been associated with osteogenesis of mesenchymal
cells in vitro [44,45]. Conversely, the exposure of both cell types to
EM resulted in a down-regulation of miR-93-5p, which has been
related to angiogenesis [46]. Further, in line with their known role
in adipogenesis, miR-30a-5p and 378a-5p were up-regulated by
AM in both cell types: it has been demonstrated that during
adipogenic differentiation miR-30a overexpression induces the
activation of the key transcription factor PPARc [47], which in
turn positively regulates miR-378a-5p expression [48].
miRs that showed an interaction between the tissue origin and
the differentiation media are those that differentially responded to
the differentiation stimuli comparing CStC and BMStC. The four
culture media up-regulated four partially overlapping miR subsets
in CStC but not in BMStC. Gene set enrichment analysis showed
that the three miRs (1, 27b-3p, and 135a-5p) associated with CM
treatment of CStC has a profound impact on pathways related to
the regulation of muscle differentiation. Of note, miR-133a was
also significantly up-regulated by CM in both cells (see Table 1).
This is in agreement with the known role played by miR-1 and
miR-133, which are highly expressed in cardiac muscle cells and
are critical regulators of muscle differentiation and proliferation
[49,50]. Consistently, miR-27b, which was also up-regulated by
AM in CStC, has been shown to have an enhanced myocardial
expression during heart development [51], and to impair human
adipocyte differentiation by targeting PPARc [52]. On the other
hand, miR-135a-5p suppressed 3T3-L1 preadipocyte differentia-
tion and adipogenesis through the activation of canonical Wnt/b-
catenin signaling [53]. Overexpression of miR-142, another miR
that we found upregulated by AM in CStC, has been shown to be
inversely related to MAPK activity in cultured cardiac myocytes,
inhibiting both survival and growth pathways and repressing
multiple components of the NF-kB pathway, and to induce
Table 2. Cont.
Term ID Description N* %{ P-value`
GO:0010608 posttranscriptional regulation of gene expression 6 8.6 2.40E-03
GO:0006915 apoptosis 9 12.9 4.87E-03
GO:0030278 regulation of ossification 4 5.7 4.98E-03
hsa04510 Focal adhesion 8 11.4 4.27E-04
hsa04722 Neurotrophin signaling pathway 6 8.6 1.64E-03
hsa04512 ECM-receptor interaction 4 5.7 2.10E-02
*Number of genes belonging to a given GO or KEGG gene set with respect to the total validated targets for a given miR.
{Percentage of genes belonging to a given GO or KEGG gene set with respect to the total validated targets for a given miR.
`EASE score P-values.
doi:10.1371/journal.pone.0107269.t002
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extensive apoptosis and cardiac dysfunction in a model of cardiac
hypertrophy [54]. Conversely, miR-30d modulation by AM in
CStC is consistent with its reported role as a key regulator of
adipocyte development, by targeting the transcription factor
RUNX2 and stimulating adipogenesis via the modulation of this
major regulator of osteogenesis [47]. Interestingly, the expression
of myomiRs like miR-1 and miR-133b [55] was increased in CStC
compared to BMStC after osteogenic treatment, which is not
surprising considering that this medium contained Dexametha-
sone, a drug known to partially induce cardiomyogenic differen-
tiation of adult cardiac stem cells [56]. Among other miRs
specifically up-regulated by OM in CStC, miR-184 has been
shown to suppress proliferation and survival in tumor cells [57].
Importantly, the network analysis on functionally enriched
pathways showed that gene clusters related to skeletal system
morphogenesis or regulation of fat cell differentiation are not
specifically modulated by any CStC-related miR subsets, whereas
the only pathway specifically targeted by AM-related miRs was
mTOR signaling, which in turn is known to promote adipogenesis
[58]. Finally, miR-204-5p was higher in CStC both after
osteogenic and EM treatment. It has been documented that
miR-204 may act through RUNX2 to inhibit osteogenesis in
mesenchymal progenitor cells [59], and expression of miR-204 has
been widely recognized has a key factor in vascular remodeling in
pulmonary arterial hypertension [60]. Taken together this data,
along with the persistent overexpression of miR-146a, may at least
partially explained the observed greater propensity of CStC to
differentiate into cardiomyocyte-like and endothelial-like cells and
their lower adipogenic and osteogenic ability compared to
BMStC. Differentiation capacity appears most likely regulated
by a complex competitive microRNA network.
Data on miR subsets specifically affecting BMStC differentia-
tion were rather limited. Several signaling pathways, including the
bone morphogenetic protein (BMP), Wnt, Hedgehog and insulin-
like growth factor pathways, as well as transcription factors such as
PPARc and RUNX2, have been shown to modulate the balance
between adipogenesis and osteogenesis [61]. In this respect, it is
interesting to note that validated genes modulated by the two miRs
(130a-3p and 29a-3p) up-regulated by OM in BMStC, and not in
CStC, are involved in the BMP signaling pathway and in the
regulation of phosphate metabolic process, osteoblast differentia-
tion and ossification. In addition, Hedgehog is one of the pathways
specifically targeted by the BMStC signature. In line with these
data, miR-29a has been shown to protect against the adverse
actions of glucocorticoid on differentiation capacity of osteogenic
cells by regulating b-catenin acetylation [62].
The existence of a tissue molecular signature untouched by
in vitro treatment has potentially an impact on the development of
new reprogramming strategies and is in line with evidences
demonstrating that, when a specific combination of miRs
efficiently act in reprogramming one type of somatic cells, it
might not be so efficient for another cell type [12]. Further, the
finding that different, effective differentiating stimuli are not able
to erase the expression of signature miRs has potentially great
consequences for regenerative medicine, implying that the
molecular network sustaining the identity of adult cells is
apparently stronger than environmental factors, thus imposing a
barrier for the concept of adult cell transdifferentiation. In this
light, our evidences strongly suggest that reaching the goal of fully
overcoming lineage boundaries should be based necessarily on the
knowledge of the main molecular determinants of the cell type at
both the starting point and the arrival of the process.
This study has a few limitations. Despite the reliability of the
tissue-specific signature, it should be highlighted that CStC and
BMStC were exposed to differentiation media and subjected to
miR profiling after in vitro passaging. For this reason, miR
expression levels observed in our conditions may be only partially
representative of the in vivo condition. Other known cardiac myo-
miRs, such as miR-208 [9], were not up-regulated in stromal cells
after cardiomyogenic treatment. This could be due to the fact that
in vitro drug treatment does not lead to fully differentiated
Figure 7. Validation by single assay RT-qPCR. Ten miRs (were
validated by single-assay real-time PCR. The mean centered relative
expression values are plotted respectively on y-axis, for the singleplex
assays, and on the x-axis, for the arrays. All correlations were significant
with P,0.001.
doi:10.1371/journal.pone.0107269.g007
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cardiomyocytes. In fact, in our conditions, despite a considerable
increase in mRNA expression, only a very low amount of cells
(<0.05–0.1%) stained positive for the protein a-sarcomeric actin
[14] and no organized sarcomeric structures were visible after the
treatment.
In conclusion, our results demonstrated the existence of a tissue-
specific miR signature, which survived to any differentiation
stimuli, suggesting that miRs could play a role, along with other
several epigenetic factors, in determining cell identity related to
tissue origin. Importantly, our results imply that the key factor able
to in vitro abolish the tissue specific differences still have to be
discovered. Moreover, we identified miR subsets modulated by
different culture conditions in a cell-specific manner, pointing out
their importance during differentiation processes.
Supporting Information
Table S1 Average expression levels and analysis of all
informative miRs passing filtering criteria. The table
reports the miR expression profiling data, after removal of non
informative miRs: i.e. (i) miR average expression in CStC and
BMStC for each culture condition, (ii) results of the 2-way
ANOVA, and (iii) significance levels corrected for multiple
comparisons (q-values).
(XLSX)
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